Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Affinity Therapeutics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Affinity Therapeutics

Affinity Therapeutics

Affinity Therapeutics: Innovating controlled release technology for advanced wound care and hernia mesh solutions.

HQ
Cleveland, OH, US
Founded
2010
Overview
Compare
Fundraising
Employees

Affinity Therapeutics, LLC, founded to commercialize technology from Case Western Reserve University, focuses on controlled release of therapeutics using molecular interactions. Their platform aims to revolutionize therapeutic delivery in markets such as advanced wound care and hernia mesh solutions.

Affinity Therapeutics has made significant strides in therapeutic delivery, leveraging their innovative platform to achieve release rates and durations unattainable by diffusion alone. Their impact is evident in the advanced wound care and hernia mesh markets, positioning them as a leader in controlled release technology.

Affinity Therapeutics - Similar Companies

Affinergy logo

Affinergy

Aplion Medical logo

Aplion Medical

aplionmedical.com

Affinia Therapeutics logo

Affinia Therapeutics

affiniatx.com

Affini-T Therapeutics logo

Affini-T Therapeutics

affinittx.com

WoundForce logo

WoundForce

Medtric logo

Medtric

medtricbiotech.com

Amnio Technology logo

Amnio Technology

Affigen logo

Affigen

affigen.com

Therapyx logo

Therapyx

therapyxinc.com

Theradaptive logo

Theradaptive

theradaptive.com

Alafair Biosciences logo

Alafair Biosciences

Arch Therapeutics logo

Arch Therapeutics

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

AffaMed Therapeutics logo

AffaMed Therapeutics

affamed.com

RenovoDerm logo

RenovoDerm

Affinity Therapeutics - Quick Facts

Who are Affinity Therapeutics' competitors?

Companies similar to Affinity Therapeutics include Affinergy, Aplion Medical, Affinia Therapeutics and Affini-T Therapeutics.

When was Affinity Therapeutics founded?

Affinity Therapeutics was founded in 2010.

Where is Affinity Therapeutics' headquarters located?

Affinity Therapeutics' headquarters is located in Cleveland, OH, US.

When was Affinity Therapeutics' last funding round?

Affinity Therapeutics' most recent funding round was for $400k (USD) in January 2014.

How much has Affinity Therapeutics raised to-date?

As of Jan 9, 2014, Affinity Therapeutics has raised a total of $550k (USD).

How many employees does Affinity Therapeutics have?

Affinity Therapeutics has 6 employees as of Feb 4, 2024.

Affinity Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Hernia Mesh
  • Wound Care
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research